Aigh Capital Management LLC Aveo Pharmaceuticals, Inc. Transaction History

Aigh Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$8.48 - $14.97 $17.3 Million - $30.6 Million	-2,043,897 Reduced 74.62%	695,358 $10.4 Million
Q3 2022 Nov 10, 2022	SELL	$6.61 - $8.72 $1.38 Million - $1.82 Million	-208,339 Reduced 7.07%	2,739,255 $22.5 Million
Q2 2022 Aug 12, 2022	BUY	$3.51 - $6.67 $447,303 - $850,004	127,437 Added 4.52%	2,947,594 $19.3 Million
Q1 2022 May 12, 2022	BUY	$3.15 - $6.01 $830,204 - $1.58 Million	263,557 Added 10.31%	2,820,157 $15.8 Million
Q4 2021 Feb 10, 2022	BUY	$4.69 - $7.4 $2.68 Million - $4.22 Million	570,424 Added 28.72%	2,556,600 $12 Million
Q3 2021 Nov 12, 2021	BUY	$5.12 - $6.89 $10.2 Million - $13.7 Million	1,986,176 New	1,986,176 $12.3 Million

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.